Company · CIK 1944552
Adlai Nortye Group Ltd.
| CIK | 1944552 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Listed | ANL (Nasdaq) |
| First annual or quarterly report | 2024-04-19 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294173 | 2026-03-10 | 2026-09-15 | 3 | |
| 333-273465 | 2023-07-27 | 2023-09-29 | 7 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-15 | EFFECTDeclared effective | 333-294173 | 9999999995-26-002965 |
| 2026-04-28 | EFFECTDeclared effective | 333-294173 | 9999999995-26-001356 |
| 2026-03-10 | F-3Shelf registered | 333-294173 | 0001213900-26-025453 |
| 2023-09-29 | 424B4Final prospectus | 333-273465 | 0001104659-23-105297 |
| 2023-09-28 | EFFECTDeclared effective | 333-273465 | 9999999995-23-002812 |
| 2023-09-27 | F-1/AAmendment | 333-273465 | 0001104659-23-104202 |
| 2023-09-12 | F-1/AAmendment | 333-273465 | 0001104659-23-099883 |
| 2023-08-14 | F-1/AAmendment | 333-273465 | 0001104659-23-091391 |
| 2023-08-10 | F-1/AAmendment | 333-273465 | 0001104659-23-089790 |
| 2023-07-27 | F-1Registration filed | 333-273465 | 0001104659-23-084478 |
| 2022-12-21 | DRSDraft made public | 377-06518 | 0001104659-22-128831 |